Volume 3, Issue 12.
In this podcast, Dr. Roma Gianchandani from the University of Michigan identifies scenarios in which patients can benefit from ultralong-acting insulins and discuss the potential negatives of ultralong-acting insulins.
Take our post-test to claim CME credits:
To read a companion newsletter click here.
Podcast (ediabetes): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS